Pharmcology of Migraine Headache Flashcards
(44 cards)
Effective medications for the management of many acute migraine attacks
Simple Analgesics and NSAIDs
An option when migraine-associated nausea and vomiting are severe
Suppository preparations of simple analgesics and NSAIDs
Analgesics that have demonstrated the most consistent evidence of efficacy include
Acetominophen and acetominophen/aspirin/caffeine (excedrin migraine)
NSAIDS that have demonstrated the most consistent evidence of efficacy include
Aspirin, Ibuprofen, Naproxen, and Diclofenac
Appear to prevent neurogenically-mediated inflammation in the trigeminovascular system by inhibiting cyclooxygenase (COX)-mediated prostaglandin synthesis
Analgesics and NSAIDs
Should be avoided or used cautiously in patients with previous ulcer disease, renal disease, or hypersensitivity to aspirin
Analgesics and NSAIDs
Migraine-specific medications, and their introduction represented a major advance in migraine pharmacotherapy
Seratonin receptor agonists (triptans)
They are appropriate first-line therapy for patients with mild-to-severe migraine, and are used for rescue therapy when non-specific medications (e.g., analgesics and NSAIDS) are ineffective
Triptans
The different triptans differ primarily with regard to pharmacokinetics and pharmacodynamics. Slower onset of action and reduced efficacy are seen with
Frovatriptan and Naratriptan
That said, frovatriptan and naratriptan also have the longest half-lives and therefore less
Headache recurrence
Selective agonists at serotonin 5-HT1B and 5-HT1D receptors
Triptans
Relief of migraine is the result of three key actions:
1) Normalization of dilated intracranial arteries through enhanced vasoconstriction.
2) Inhibition of vasoactive peptide release from perivascular trigeminal neurons.
3) Inhibition of transmission through second-order neurons ascending to the thalamus
Triptans
What are some of the mild adverse effects of Triptans?
Paresthesias, dizziness, fatigue, and flushing
Up to 25% of patients receiving triptans report tightness, pressure, heaviness, or pain in the
Chest, neck, or throat
The triptans are partial agonists at 5-HT coronary artery receptors, and are therefore contraindicated in patients with a history of
Ischemic heart disease, uncontrolled hypertension, and cerebrovascular disease
The triptans should not be given to patients receiving
SSRIs or SNRIs
Can be considered for the treatment of moderate-to severe migraine attacks
-Their use, however, is limited by issues of efficacy and side effects
Ergotamine tartrate and dihydroergotamine
Ergotamine is available in oral, sublingual, and rectal preparations, with dihydroergotamine being available for
Intranasal and parenteral administration
Non-selective agonists at serotonin 5-HT1 receptors.
-Cause constriction of intracranial blood vessels and inhibit the development of neurogenic inflammation in the trigeminovascular system
Ergot Alkaloids and Derivatives (Ergotamine tartrate and dihydroergotamine)
Central inhibition of the trigeminovascular pathway has also been reported with
Ergot Alkaloids and Derivatives (Ergotamine tartrate and dihydroergotamine)
Among the most common adverse effects to Ergotamine tartrate and dihydroergotamine
Nausea and vomiting
Contraindicated in patients with renal or hepatic failure; coronary, cerebral, or peripheral vascular disease; uncontrolled hypertension, and sepsis
Ergotamine tartrate and dihydroergotamine
Ergotamine tartrate and dihydroergotamine are also contraindicated in women who are
Pregnant or nursing
Among the most widely used drugs for migraine prophylaxis
B-Adrenergic antagonists (B-blockers)